
SK Chemicals Co., a petrochemical unit of South Korea's third-largest conglomerate SK Group, said Wednesday that it has signed a deal with global vaccine maker Sanofi Pasteur Inc. to jointly develop and sell a next-generation vaccine. SK Chemicals will develop the vaccine for pneumococcal with Sanofi Pasteur and produce it at its plant in Andong, 268 kilometers southeast of Seoul, the company said in a regulatory filing. Pneumococcal is a bacterial infection responsible for up to 1.6 million deaths a year worldwide, according to the World Heath Organization.
GMT 09:47 2018 Tuesday ,23 January
SAP unveils big push into French tech start-upsGMT 05:07 2018 Tuesday ,23 January
Noble Group shares surge 37 percent on buyout talksGMT 19:07 2018 Monday ,22 January
BAKS spent Dh225m on charity projects in 2017GMT 22:52 2018 Sunday ,21 January
French firm "recalls baby milk product"GMT 22:27 2018 Sunday ,21 January
US company plans funds that double bitcoin price movesGMT 21:23 2018 Sunday ,21 January
Pence starts Mideast tour in Egypt amid Arab angerGMT 08:54 2018 Saturday ,20 January
Million-euro bill for firm behind Paris bike-share chaosGMT 10:47 2018 Friday ,19 January
German chemical giant BASF sees 'significant' profit leap

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor